Mereo BioPharma Group plc (MREO)

Stammdaten

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was incorporated in 2015 and is based in London, the United Kingdom.

Unternehmen & Branche

NameMereo BioPharma Group plc
TickerMREO
CIK0001719714
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP589492107
ISINUS5894921072
TypADR
Marktkapitalisierung52,4 Mio. USD
Beta0,38
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K500,000-41,878,000-0.0545,917,00040,916,000
2025-09-3010-Q0-7,024,000-0.0153,602,00046,598,000
2025-06-3010-Q500,000-14,616,000-0.0262,631,00054,177,000
2025-03-3110-Q-12,887,000-0.0268,322,00060,081,000
2024-12-3110-K0-43,253,000-0.0676,390,00060,969,000
2024-09-3010-Q0-15,001,000-0.0288,746,000-72,536,000
2024-06-3010-Q0-12,255,000-0.0296,129,00078,650,000
2024-03-3110-Q0-8,951,000-0.0155,937,00042,838,000
2023-12-3110-K10,000,000-29,466,000-0.0466,499,00050,537,000
2023-09-3010-Q0-6,531,000-0.0154,706,000
2023-06-3010-Q9,000,000-1,751,0000.0049,665,000
2023-03-3110-Q0-12,076,000-0.0244,400,000
2022-12-3110-K0-42,220,000-0.0777,413,00051,402,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Rubric Capital Management LP15,307,347015,307,3476,378,572Neu+100,0%
683 Capital Management, LLC15,025,000015,025,0006,260,917Neu+100,0%
Schonfeld Strategic Advisors LLC6,090,38106,090,3812,537,860Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,763,66601,763,666735,449Neu+100,0%
Monaco Asset Management SAM1,585,21401,585,214660,559Neu+100,0%
UBS Group AG1,558,93101,558,931650,074Neu+100,0%
MORGAN STANLEY1,273,78501,273,785530,787Neu+100,0%
SIMPLEX TRADING, LLC1,173,17701,173,177489,213Neu+100,0%
GROUP ONE TRADING LLC1,168,03601,168,036486,721Neu+100,0%
JANE STREET GROUP, LLC873,7040873,704364,073Neu+100,0%
CITADEL ADVISORS LLC748,7000748,700311,983Neu+100,0%
DLD Asset Management, LP746,0000746,000310,858Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP694,1000694,100291,522Neu+100,0%
TWO SIGMA INVESTMENTS, LP525,1250525,125218,820Neu+100,0%
EntryPoint Capital, LLC400,7000400,700166,972Neu+100,0%
BlackRock, Inc.312,6130312,613130,265Neu+100,0%
Quadrature Capital Ltd266,7310266,731111,147Neu+100,0%
SPHERA FUNDS MANAGEMENT LTD.255,4000255,400106,425Neu+100,0%
CITIGROUP INC195,8140195,81481,596Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC194,3710194,37180,994Neu+100,0%
ADAR1 Capital Management, LLC150,0000150,00062,505Neu+100,0%
STATE STREET CORP130,6430130,64354,439Neu+100,0%
Virtus Investment Advisers, LLC122,5950122,59551,085Neu+100,0%
Graham Capital Management, L.P.116,2860116,28648,456Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC92,534092,53438,558Neu+100,0%
MILLENNIUM MANAGEMENT LLC83,646083,64634,855Neu+100,0%
Baader Bank Aktiengesellschaft128,7420128,74233,081Neu+100,0%
Caption Management, LLC50,000050,00020,835Neu+100,0%
Engineers Gate Manager LP49,798049,79820,751Neu+100,0%
Forefront Analytics, LLC31,768031,76813,238Neu+100,0%
GOLDMAN SACHS GROUP INC28,026028,02611,678Neu+100,0%
BANK OF AMERICA CORP /DE/25,492025,49210,604Neu+100,0%
Aquatic Capital Management LLC21,216021,2168,841Neu+100,0%
SmartHarvest Portfolios, LLC20,290020,2908,455Neu+100,0%
BARCLAYS PLC20,100020,1008,376Neu+100,0%
RHUMBLINE ADVISERS19,146019,1467,977Neu+100,0%
Three Magnolias Financial Advisors, LLC19,000019,0007,917Neu+100,0%
OneDigital Investment Advisors LLC18,300018,3007,626Neu+100,0%
Newbridge Financial Services Group, Inc.17,000017,0007,084Neu+100,0%
AE Wealth Management LLC12,563012,5635,235Neu+100,0%
MML INVESTORS SERVICES, LLC12,200012,2005,084Neu+100,0%
Astoria Portfolio Advisors LLC.10,000010,0004,026Neu+100,0%
GAMMA Investing LLC9,56109,5613,984Neu+100,0%
TORONTO DOMINION BANK5,50005,5002,294Neu+100,0%
Arax Advisory Partners4,00004,0001,667Neu+100,0%
Caitong International Asset Management Co., Ltd2,23102,231930Neu+100,0%
Rockefeller Capital Management L.P.2,00002,000833Neu+100,0%
WELLS FARGO & COMPANY/MN1,73701,737724Neu+100,0%
Allworth Financial LP1,61101,611672Neu+100,0%
OSAIC HOLDINGS, INC.5000500208Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-316620,32212
2026-03-2413.4620,344.577
2026-03-1650,392
2026-03-124.0000,401.600
2026-03-111.0310,40412
2026-03-04180,417
2026-03-033940,40158
2026-03-024.5960,371.701
2026-02-2610.0250,393.910
2026-02-2561.5640,4024.626
2026-02-2070,433
2026-02-1911.3440,424.764
2026-02-185.0310,422.113
2026-02-1711.3000,374.181

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
Rubric Capital Management LP15,307,3476,378,57229.82
683 Capital Management, LLC15,025,0006,260,91729.27
Schonfeld Strategic Advisors LLC6,090,3812,537,86011.87
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,763,666735,4493.44
Monaco Asset Management SAM1,585,214660,5593.09
UBS Group AG1,558,931650,0743.04
MORGAN STANLEY1,273,785530,7872.48
SIMPLEX TRADING, LLC1,173,177489,2132.29
GROUP ONE TRADING LLC1,168,036486,7212.28
JANE STREET GROUP, LLC873,704364,0731.70
CITADEL ADVISORS LLC748,700311,9831.46
DLD Asset Management, LP746,000310,8581.45
SUSQUEHANNA INTERNATIONAL GROUP, LLP694,100291,5221.36
TWO SIGMA INVESTMENTS, LP525,125218,8201.02
EntryPoint Capital, LLC400,700166,9720.78
BlackRock, Inc.312,613130,2650.61
Quadrature Capital Ltd266,731111,1470.52
SPHERA FUNDS MANAGEMENT LTD.255,400106,4250.50
CITIGROUP INC195,81481,5960.38
RENAISSANCE TECHNOLOGIES LLC194,37180,9940.38

Hinweis

Erweitert ×